1[1]Van den Berghe G, Wouters PJ, Weekers F, et al. Intensive insulin therapy in the critically ill patients[J]. N Engl J Med, 2001,345(19):1359- 1367.
2[2]Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill:insulin dose versus glycemic control[J]. Crit Care Med, 2003,31:359- 366.
3[3]Chiolero R, Revelly JP, Tappy L. Energy metabolism in sepsis and injury [J]. Nutrition, 1997,13(9 Suppl) :45S - 51S.
4[4]Johan Groeneveld AB, Beishuizen A, Visser FC. Insulin: a wonder drug in the critically ill[J]? Crit Care, 2002,6(2): 102 - 105.
5[5]Writing Team for the Diabetes Control and Complications Trial/Epideniology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus[J]. JAMA, 2002,287(19):2563-2569.
6[6]Kwoun MO, Ling PR, Lydon E, et al . Immunologic effects of acute hyperglycemia in nondiabetic rats [ J]. JPEN J Parenter Enteral Nutr,1997, 21(2) :91 - 95..
8[8]Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose - binding lectin levels [ J ]. J Clin Endocrinol Metab, 2003,88 (3): 1082 - 1088.
9[9]Klas Malmberg, Anna Norhammar, Hans Wedel. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial Infarction [ J ].Circulation, 1999,99: 2626 - 2632.
10[10]Klas Malmberg. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus[J]. BMJ, 1997,314:1512.
二级参考文献6
1Qiang Pu Chen Department of Heptobiliary Surgery, The Affiliated Hospital of Binzhou Medical College, Binzhou 256603, Shandong Province, China.Enteral nutrition and acute pancreatitis[J].World Journal of Gastroenterology,2001,7(2):185-192. 被引量：15
2Guo Liang Zhang Ye Hong Wang Hui Ling Teng Zhi Bin Lin Department of Pharmacology,School of Basic Medical Sciences,Beijing University,Beijiog 100083,ChinaDr.Guo Liang Zhang graduated from Xinxiang Medical College in 1982,got Ph.D.at Nagoya City University Medical School,Japan in 1994,finished postdoctoral research at Beijing Medical Univcrsity in 1996,now an associate professor of pharmacology,specialized in hepatic pharmacology,having 15 papers published..Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes[J].World Journal of Gastroenterology,2001,7(3):331-334. 被引量：20
